Anavex Life Sciences Corp (AVXL)

[falconer66a]

The market won’t make Anavex 2-73.

Market wants to know 273 works for alz....

No, the reality is this. The “market” simply has nothing to say or contribute to Anavex 2-73 (blarcamesine) ever being sold or used for disease therapies. That’s the function of the Food and Drug Administration (FDA). They, solely (in the US, at least), decide if blarcamesine “works;” after, of course, considering clinical results data. And those won’t be available until later.

Gonna have to wait. Pretty tough to do, it appears.